Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
75
Top-10 weight
36.99%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
42
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
764.2
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | ABBVIE INC | — | 45,923 | $9.99M | 7.39% |
| 2 | AMGEN INC | — | 20,093 | $7.07M | 5.23% |
| 3 | GILEAD SCIENCES INC | — | 48,042 | $6.70M | 4.96% |
| 4 | VERTEX PHARMACEUTICALS INC | — | 12,119 | $5.41M | 4.01% |
| 5 | REGENERON PHARMACEUTICALS INC | — | 6,224 | $4.81M | 3.56% |
| 6 | ALNYLAM PHARMACEUTICALS INC | — | 10,632 | $3.52M | 2.60% |
| 7 | INSMED INC | — | 20,277 | $3.32M | 2.45% |
| 8 | BEONE MEDICINES LTD ADR | — | 10,395 | $3.09M | 2.29% |
| 9 | NATERA INC | — | 14,145 | $2.83M | 2.09% |
| 10 | UNITED THERAPEUTICS CORP DEL | — | 4,711 | $2.79M | 2.07% |
| 11 | BIOGEN INC | — | 14,803 | $2.71M | 2.01% |
| 12 | ROYALTY PHARMA PLC | — | 55,739 | $2.67M | 1.98% |
| 13 | ILLUMINA INC | — | 19,053 | $2.35M | 1.74% |
| 14 | REVOLUTION MEDICINES INC | — | 23,475 | $2.28M | 1.69% |
| 15 | MODERNA INC | — | 43,818 | $2.23M | 1.65% |
| 16 | ASTRAZENECA PLC | — | 10,974 | $2.16M | 1.60% |
| 17 | ARGENX SE SPONSORED ADR | — | 2,961 | $2.16M | 1.60% |
| 18 | INCYTE CORP | — | 22,317 | $2.10M | 1.56% |
| 19 | VIATRIS INC | — | 150,073 | $2.03M | 1.50% |
| 20 | BRIDGEBIO PHARMA INC | — | 26,764 | $1.99M | 1.47% |
| 21 | ALKERMES PLC | — | 56,068 | $1.98M | 1.47% |
| 22 | JAZZ PHARMA PLC | — | 10,448 | $1.98M | 1.46% |
| 23 | NEUROCRINE BIOSCIENCES INC | — | 14,527 | $1.91M | 1.42% |
| 24 | GUARDANT HEALTH INC | — | 20,606 | $1.90M | 1.41% |
| 25 | ROIVANT SCIENCES LTD | — | 68,372 | $1.89M | 1.40% |
| 26 | IONIS PHARMACEUTICALS INC | — | 24,870 | $1.87M | 1.38% |
| 27 | EXELIXIS INC | — | 40,607 | $1.74M | 1.29% |
| 28 | MEDPACE HOLDINGS INC | — | 3,540 | $1.70M | 1.26% |
| 29 | BIOMARIN PHARMACEUTICAL INC | — | 29,738 | $1.68M | 1.24% |
| 30 | APELLIS PHARMACEUTICALS INC | — | 41,107 | $1.65M | 1.22% |
| 31 | ARROWHEAD PHARMACEUTICALS INC | — | 26,370 | $1.65M | 1.22% |
| 32 | CYTOKINETICS INC | — | 24,093 | $1.59M | 1.18% |
| 33 | VAXCYTE INC | — | 26,383 | $1.53M | 1.14% |
| 34 | CRISPR THERAPEUTICS AG | — | 32,054 | $1.52M | 1.13% |
| 35 | HALOZYME THERAPEUTICS INC | — | 22,712 | $1.47M | 1.09% |
| 36 | BIONTECH SE ADR | — | 16,159 | $1.44M | 1.06% |
| 37 | AXSOME THERAPEUTICS INC | — | 8,171 | $1.38M | 1.02% |
| 38 | Ascendis Pharma A/S | — | 5,974 | $1.37M | 1.01% |
| 39 | COGENT BIOSCIENCES INC | — | 34,752 | $1.34M | 0.99% |
| 40 | ARCELLX INC | — | 11,645 | $1.34M | 0.99% |
| 41 | TG THERAPEUTICS INC | — | 39,225 | $1.30M | 0.96% |
| 42 | PTC THERAPEUTICS INC | — | 18,935 | $1.29M | 0.96% |
| 43 | SCHOLAR ROCK HOLDING CORP | — | 25,883 | $1.27M | 0.94% |
| 44 | MADRIGAL PHARMACEUTICALS INC | — | 2,329 | $1.22M | 0.90% |
| 45 | MIRUM PHARMACEUTICALS INC | — | 13,080 | $1.21M | 0.89% |
| 46 | PROTAGONIST THERAPEUTICS INC | — | 11,198 | $1.18M | 0.87% |
| 47 | AMICUS THERAPEUTICS INC | — | 76,280 | $1.10M | 0.82% |
| 48 | RHYTHM PHARMACEUTICALS INC | — | 12,158 | $1.06M | 0.78% |
| 49 | APOGEE THERAPEUTICS INC | — | 12,066 | $1.02M | 0.75% |
| 50 | KYMERA THERAPEUTICS INC | — | 11,658 | $970.99K | 0.72% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.